
Heart failure (HF) is a complex, systemic cardiovascular condition characterized by a severe impairment in O 2 transport to skeletal muscle that drives exercise intolerance and reduces quality of life. Although exercise training (ET) is a cornerstone of HF clinical management, patients often exhibit limited improvements in peak oxygen uptake () following traditional whole‐body, aerobic exercise recruiting a large muscle mass (e.g., cycling). In patients with HF, adaptations within skeletal muscle (e.g., capillarization) exert a proportionally greater influence on changes in than adaptations in cardiac performance. In this review, we discuss the mechanisms by which traditional ET prescription may be suboptimal to elicit peripheral adaptations and argue that dynamic exercise recruiting only a small muscle mass (e.g., quadriceps) may be more effective in achieving this goal. Indeed, small muscle mass exercise reduces the cardiovascular restraints imposed by the failing heart, allowing the muscle to reach much greater metabolic rates and to be exposed to much larger degrees of homeostatic perturbations, a key factor triggering adaptations in O 2 transport and utilization at the peripheral level. The intent of this review is to discuss the influence of muscle mass on exercise tolerance and adaptations to ET in HF, with the ultimate goal of promoting the integration of small muscle mass exercise into contemporary cardiac rehabilitation programmes.
Abstract Congestive heart failure (CHF) is associated with profound cardiac metabolic remodelling, particularly in lipid utilization. While Hedan Pill and Shexiang Baoxin Pill are traditional Chinese medicines with cardiovascular benefits, their synergistic mechanisms in CHF remain unclear. Network pharmacology and molecular docking were combined with in vivo validation using ApoE −/− mice fed a high‐fat diet and subjected to isoproterenol (ISO) treatment. Animals were allocated to seven groups: control, model, Entresto, Hedan Pill, Shexiang Baoxin Pill, Entresto + Hedan Pill, and Entresto + Shexiang Baoxin Pill. Cardiac function, serum lipids, myocardial histopathology, and protein expression of peroxisome proliferator‐activated receptor α (PPARα), carnitine palmitoyltransferase 1A (CPT1A) and sterol regulatory element‐binding protein 1c (SREBP‐1c) were assessed. Network analysis indicated convergence on the PPARα–lipid metabolism pathway, with strong binding affinities between several active compounds and PPARα (≤ −7.0 kcal mol −1 ). In vivo, Hedan Pill or ShexiangBaoxin Pill alone improved ejection fraction, reduced triglycerides, and alleviated fibrosis and lipid deposition. Compared with Entresto alone, both combination regimens further reduced serum triglycerides and LDL‐C, whereas ejection fraction did not differ significantly. Mechanistically, both agents upregulated myocardial PPARα and CPT1A while suppressing SREBP‐1c. Hedan Pill and Shexiang Baoxin Pill synergistically improve cardiac lipid metabolic homeostasis through the PPARα–CPT1A axis, thereby protecting against CHF‐induced myocardial injury. These findings provide physiological and mechanistic evidence supporting their translational potential as complementary interventions in CHF.
Abstract Interval training (INT) of sufficient frequency, intensity and duration can increase biomarkers of skeletal muscle oxidative capacity in humans. Studies typically involve three to four sessions per week; however, the effect of reduced training frequency on this response is unclear. Most studies also do not include a non‐exercise control (CON) condition to account for the potential influence of extraneous, uncontrolled factors. We employed a single‐leg, counterweighted cycling model to investigate the effect of twice weekly INT for 6 weeks on biomarkers of skeletal muscle oxidative capacity including mitochondrial content and fibre capillarisation. Sixteen healthy active adults (6 males, 10 females; 22 ± 3 years; peak oxygen uptake: 36.1 ± 6.1 mL kg −1 min −1 ) performed INT with one leg and their contralateral limb served as a CON. INT involved 4 × 5‐min bouts at an intensity of 50%–60% W peak , interspersed with 2.5 min of recovery at 20% W peak . Muscle biopsy samples obtained from the vastus lateralis of both legs before and after the intervention revealed no differences in the primary outcome measure, citrate synthase maximal activity ( P = 0.350, time × leg interaction). There were also no differences in multiple markers of mitochondrial protein content or capillarisation (all P > 0.05), except NDUFB8 protein content, which increased post‐training in the INT leg only ( P = 0.0387). The lack of change in most biomarkers of oxidative capacity may be due to an insufficient training intensity or related to participant fitness or measurement variability as indicated by the typical error of ∼20%˗40% between legs as baseline.
Abstract Hyperthermia can increase gastrointestinal permeability, allowing microbes to leak from the intestinal lumen to the hepatic portal and systemic circulation. However, the extent to which sex and menstrual cycle hormones impact the risk of increased gastrointestinal permeability during heat stress is unclear. Twenty‐four healthy young adults [12 male, 24 ± 3 years old; 12 female (5 oral contraceptive users), 23 ± 2 years old] participated in the study. Initially, participants completed a control trial (no heat or exercise) to determine baseline gastrointestinal permeability. Then, participants took part in a hyperthermia trial, in which deep body temperature was increased by +1.5°C from baseline via a water‐perfused suit combined with semi‐recumbent cycling at 40 W. Oestradiol was measured at baseline during the hyperthermia trial. In both trials, permeability was assessed by measuring the urinary excretion of orally ingested sucrose (10 g) and the lactulose/rhamnose ratio (L/R, 1 g each) to assess gastroduodenal and small intestinal permeability, respectively. Data are presented as the change in excretion from control to hyperthermia. Pooled analysis of all participants identified that hyperthermia increased small intestinal permeability [ΔL/R = 0.012 ± 0.029 (95% confidence interval 0.000 to 0.025), P = 0.050, = 0.43]. Although there were no sex differences at the group level, we identified a strong positive correlation between ΔL/R and baseline oestradiol concentration within females ( r = 0.709, P = 0.040). Gastroduodenal permeability did not increase with hyperthermia ( P = 0.136), nor were there any differences between the sexes ( P = 0.411). Future studies should confirm whether oestradiol plays an independent role in modulating heat‐induced gastrointestinal permeability in humans.
Abstract Ceiling fans are a low‐energy strategy for reducing heat strain, but their ability to protect against subclinical cellular and organ stress is unknown. We examined circulating stress biomarkers in 20 older adults (12 females; median age 71 years), who completed randomized 8 h exposures to 31°C and 45% relative humidity while remaining reclined beneath a ceiling fan delivering 0 m s −1 (control) or 1.5 m s −1 (fan). Venous blood was collected before and after each exposure and analysed for serum intestinal fatty acid‐binding protein (IFABP), soluble cluster of differentiation 14 (sCD14), kidney injury molecule‐1, neutrophil gelatinase‐associated lipocalin, tumour necrosis factor‐α, interleukin‐6 and C‐reactive protein. Core temperature and heart rate were measured continuously. Biomarker responses were assessed using baseline‐adjusted linear mixed‐effects models with Holm correction for multiple testing. Fan use lowered peak core temperature and heart rate by 0.2°C ( P < 0.001) and 5 beats min −1 ( P = 0.030), respectively. The adjusted difference in IFABP change between control and fan was 344 pg mL −1 [95% confidence interval: 102–586] (unadjusted P = 0.005; Holm‐adjusted P = 0.035). Across conditions, the estimated changes in IFABP and sCD14 were 240 pg mL −1 [95% confidence interval: 11–468] (Holm‐adjusted P = 0.240) and 0.57 ng mL −1 [95% confidence interval: 0.10–1.03] (Holm‐adjusted P = 0.119), respectively. No other biomarker comparisons remained significant after Holm adjustment. Ceiling‐fan use at 31°C attenuated the IFABP response in bed‐resting older adults despite modest effects on core temperature and heart rate. These exploratory findings suggest that fan‐mediated protection might extend beyond changes captured by conventional physiological measures, but confirmation in prospectively powered studies incorporating direct measures of gastrointestinal permeability is required.